Top Markets
#1 Tutorial Tutorial +48.51%
#2 Unit Pump Unit Pump +24.64%
#3 Pump.fun Pump.fun +24.64%
#4 Siacoin Siacoin +24.49%
#5 Official Trump Official Trump +23.94%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +22.43%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.13%
#9 Stacks Stacks +18.09%
#10 LayerZero LayerZero +17.67%
Coin of the day
Tutorial Tutorial
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Rang in aandelen #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Aandeelprijs
$0.97305026
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$85.54M
Verandering (1 dag)
1.16%
Verandering (1 jaar)
-50.40%
Land
TW
Handel Energenesis Biomedical CO.,LTD. (6657)

Categorie

Healthcare
Winst voor Energenesis Biomedical CO.,LTD. (6657)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Energenesis Biomedical CO.,LTD. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Energenesis Biomedical CO.,LTD. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH